NASDAQ Biotechnology Index (NBI) Companies by Market Cap
The NASDAQ Biotechnology Index (NBI) tracks 263 constituent companies with a combined market cap of $1.75 Trillion, covering the largest publicly traded companies in USA. This ranking lists all NBI index holdings ordered by market capitalization — from the largest index heavyweights to smaller constituents. Updated daily with live market data.
Total Market Cap (USD)
$1.75 Trillion
Constituent Companies
263
Index Country
USA
| Rank | Company | Weight (%) | Market Cap (USD) | Sector | Industry | Price | 24h Change |
|---|---|---|---|---|---|---|---|
| 1 |
AstraZeneca PLC
NASDAQ:AZN |
% | $282.04 Billion | Healthcare | Drug Manufacturers - General | $187.03 | -1.43% |
| 2 |
Amgen Inc
NASDAQ:AMGN |
% | $195.87 Billion | Healthcare | Drug Manufacturers - General | $363.39 | -0.06% |
| 3 |
Gilead Sciences Inc
NASDAQ:GILD |
% | $161.08 Billion | Healthcare | Drug Manufacturers - General | $129.83 | -3.72% |
| 4 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
% | $110.45 Billion | Healthcare | Biotechnology | $485.39 | -2.24% |
| 5 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
% | $64.60 Billion | Healthcare | Biotechnology | $664.52 | -0.51% |
| 6 |
argenx NV ADR
NASDAQ:ARGX |
% | $45.97 Billion | Healthcare | Biotechnology | $787.95 | -0.66% |
| 7 |
Revolution Medicines Inc
NASDAQ:RVMD |
% | $39.73 Billion | Healthcare | Biotechnology | $186.88 | -2.22% |
| 8 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
% | $39.62 Billion | Healthcare | Biotechnology | $298.76 | -4.49% |
| 9 |
Biogen Inc
NASDAQ:BIIB |
% | $27.74 Billion | Healthcare | Drug Manufacturers - General | $199.15 | +0.12% |
| 10 |
Royalty Pharma Plc
NASDAQ:RPRX |
% | $25.01 Billion | Healthcare | Biotechnology | $56.43 | -2.64% |
| 11 |
Insmed Inc
NASDAQ:INSM |
% | $24.66 Billion | Healthcare | Biotechnology | $115.61 | -2.24% |
| 12 |
United Therapeutics Corporation
NASDAQ:UTHR |
% | $21.42 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $547.06 | -0.98% |
| 13 |
Roivant Sciences Ltd
NASDAQ:ROIV |
% | $20.44 Billion | Healthcare | Biotechnology | $35.97 | -2.28% |
| 14 |
Incyte Corporation
NASDAQ:INCY |
% | $20.04 Billion | Healthcare | Biotechnology | $116.71 | -1.53% |
| 15 |
Moderna Inc
NASDAQ:MRNA |
% | $19.49 Billion | Healthcare | Biotechnology | $68.27 | -10.83% |
| 16 |
Viatris Inc
NASDAQ:VTRS |
% | $18.95 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $16.27 | -0.43% |
| 17 |
Illumina Inc
NASDAQ:ILMN |
% | $18.34 Billion | Healthcare | Diagnostics & Research | $190.20 | -1.84% |
| 18 |
Genmab AS
NASDAQ:GMAB |
% | $16.23 Billion | Healthcare | Biotechnology | $29.00 | -2.62% |
| 19 |
Medpace Holdings Inc
NASDAQ:MEDP |
% | $15.19 Billion | Healthcare | Diagnostics & Research | $538.23 | +0.51% |
| 20 |
Ascendis Pharma AS
NASDAQ:ASND |
% | $14.74 Billion | Healthcare | Biotechnology | $270.45 | -1.81% |
| 21 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
% | $14.42 Billion | Healthcare | Biotechnology | $85.89 | -4.75% |
| 22 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
% | $14.17 Billion | Healthcare | Biotechnology | $243.82 | -1.25% |
| 23 |
Neurocrine Biosciences Inc
NASDAQ:NBIX |
% | $13.03 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $177.11 | -1.91% |
| 24 |
Guardant Health Inc
NASDAQ:GH |
% | $12.69 Billion | Healthcare | Diagnostics & Research | $160.05 | -2.46% |
| 25 |
Exelixis Inc
NASDAQ:EXEL |
% | $12.17 Billion | Healthcare | Biotechnology | $56.50 | -1.05% |
| 26 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
% | $12.03 Billion | Healthcare | Biotechnology | $233.80 | -6.09% |
| 27 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
% | $11.90 Billion | Healthcare | Biotechnology | $518.74 | -1.97% |
| 28 |
Summit Therapeutics PLC
NASDAQ:SMMT |
% | $10.95 Billion | Healthcare | Biotechnology | $15.25 | -1.49% |
| 29 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
% | $10.93 Billion | Healthcare | Biotechnology | $59.12 | -1.42% |
| 30 |
Cytokinetics Inc
NASDAQ:CYTK |
% | $10.33 Billion | Healthcare | Biotechnology | $84.87 | -1.39% |
| 31 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
% | $9.81 Billion | Healthcare | Biotechnology | $119.35 | +0.29% |
| 32 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
% | $9.44 Billion | Healthcare | Biotechnology | $58.25 | -9.38% |
| 33 |
Tempus AI, Inc. Class A Common Stock
NASDAQ:TEM |
% | $9.34 Billion | Healthcare | Health Information Services | $58.23 | -5.32% |
| 34 |
Krystal Biotech Inc
NASDAQ:KRYS |
% | $9.22 Billion | Healthcare | Biotechnology | $365.81 | -1.46% |
| 35 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
% | $9.19 Billion | Healthcare | Biotechnology | $76.40 | -9.05% |
| 36 |
Nuvalent Inc
NASDAQ:NUVL |
% | $9.11 Billion | Healthcare | Biotechnology | $123.90 | +0.06% |
| 37 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
% | $8.70 Billion | Healthcare | Biotechnology | $76.20 | -3.08% |
| 38 |
Blueprint Medicines Corp
NASDAQ:BPMC |
% | $8.36 Billion | Healthcare | Biotechnology | $129.46 | +0.14% |
| 39 |
Vaxcyte Inc
NASDAQ:PCVX |
% | $7.65 Billion | Healthcare | Biotechnology | $58.21 | -2.71% |
| 40 |
Alkermes Plc
NASDAQ:ALKS |
% | $7.49 Billion | Healthcare | Drug Manufacturers - Specialty & Generic | $51.94 | -3.42% |
| 41 |
Verona Pharma PLC ADR
NASDAQ:VRNA |
% | $7.31 Billion | Healthcare | Biotechnology | $86.00 | +0.00% |
| 42 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
% | $7.08 Billion | Healthcare | Biotechnology | $324.99 | -2.44% |
| 43 |
Merus BV
NASDAQ:MRUS |
% | $6.83 Billion | Healthcare | Biotechnology | $90.00 | -7.14% |
| 44 |
Arcellx Inc
NASDAQ:ACLX |
% | $6.73 Billion | Healthcare | Biotechnology | $115.07 | +0.00% |
| 45 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
% | $6.64 Billion | Healthcare | Biotechnology | $97.74 | -1.02% |
| 46 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
% | $6.53 Billion | Healthcare | Biotechnology | $122.13 | -4.36% |
| 47 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
% | $6.24 Billion | Healthcare | Biotechnology | $133.65 | +0.06% |
| 48 |
PTC Therapeutics Inc
NASDAQ:PTCT |
% | $6.11 Billion | Healthcare | Biotechnology | $84.85 | -5.25% |
| 49 |
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
% | $6.10 Billion | Healthcare | Biotechnology | $39.43 | -0.10% |
| 50 |
Immunitybio Inc
NASDAQ:IBRX |
% | $5.96 Billion | Healthcare | Biotechnology | $8.22 | -7.33% |
Complete list of all companies in the NBI index ranked by market capitalization. Track index constituent performance and market values. View all indices